12857 related articles for article (PubMed ID: 21749752)
1. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
2. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
Audibert F; Gagnon A; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
[TBL] [Abstract][Full Text] [Related]
3. No. 261-Prenatal Screening for Fetal Aneuploidy in Singleton Pregnancies.
Chitayat D; Langlois S; Wilson RD
J Obstet Gynaecol Can; 2017 Sep; 39(9):e380-e394. PubMed ID: 28859781
[TBL] [Abstract][Full Text] [Related]
4. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
5. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
Langlois S; Duncan A; ;
J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound in twin pregnancies.
Morin L; Lim K; ; ; ;
J Obstet Gynaecol Can; 2011 Jun; 33(6):643-656. PubMed ID: 21846456
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcomes after assisted human reproduction.
Okun N; Sierra S; ;
J Obstet Gynaecol Can; 2014 Jan; 36(1):64-83. PubMed ID: 24444289
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of prenatally diagnosed structural congenital anomalies.
Gagnon A;
J Obstet Gynaecol Can; 2009 Sep; 31(9):875-881. PubMed ID: 19941713
[TBL] [Abstract][Full Text] [Related]
9. Adolescent Pregnancy Guidelines.
Fleming N; O'Driscoll T; Becker G; Spitzer RF;
J Obstet Gynaecol Can; 2015 Aug; 37(8):740-756. PubMed ID: 26474231
[TBL] [Abstract][Full Text] [Related]
10. Prenatal Diagnosis Procedures and Techniques to Obtain a Diagnostic Fetal Specimen or Tissue: Maternal and Fetal Risks and Benefits.
Wilson RD; Gagnon A; Audibert F; Campagnolo C; Carroll J;
J Obstet Gynaecol Can; 2015 Jul; 37(7):656-668. PubMed ID: 26366824
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for the Management of a Pregnant Trauma Patient.
Jain V; Chari R; Maslovitz S; Farine D; ; Bujold E; Gagnon R; Basso M; Bos H; Brown R; Cooper S; Gouin K; McLeod NL; Menticoglou S; Mundle W; Pylypjuk C; Roggensack A; Sanderson F
J Obstet Gynaecol Can; 2015 Jun; 37(6):553-74. PubMed ID: 26334607
[TBL] [Abstract][Full Text] [Related]
12. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012600. PubMed ID: 28295158
[TBL] [Abstract][Full Text] [Related]
13. [What are the real purpose and scope of screening for aneuploidy?].
Quibel T; Rozenberg P
Gynecol Obstet Fertil Senol; 2018 Feb; 46(2):124-129. PubMed ID: 29396076
[TBL] [Abstract][Full Text] [Related]
14. Canadian Contraception Consensus (Part 2 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
[TBL] [Abstract][Full Text] [Related]
15. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
Spencer K; Nicolaides KH
BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
[TBL] [Abstract][Full Text] [Related]
16. Canadian Contraception Consensus (Part 1 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
[TBL] [Abstract][Full Text] [Related]
17. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
Chen X; Chang Y; Cui HY; Ren CC; Yu BY
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
[TBL] [Abstract][Full Text] [Related]
18. Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester: (Replaces Consults #10, Single umbilical artery, October 2010; #16, Isolated echogenic bowel diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation and management of isolated renal pelviectasis on second-trimester ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts, April 2013; #27, Isolated echogenic intracardiac focus, August 2013).
; Prabhu M; Kuller JA; Biggio JR
Am J Obstet Gynecol; 2021 Oct; 225(4):B2-B15. PubMed ID: 34171388
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
[TBL] [Abstract][Full Text] [Related]
20. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]